Featured Research

from universities, journals, and other organizations

Newly identified tumor suppressor provides therapeutic target for prostate cancer

Date:
April 1, 2013
Source:
Sanford-Burnham Medical Research Institute
Summary:
Researchers have found that the enzyme PKCzeta controls the activation of a pro-tumor gene called c-Myc. Normally, PKCzeta's alteration keeps c-Myc in check. But PKCzeta levels are low in prostate and other cancers, leaving c-Myc free to enhance cell growth and metastasis.

Prostate cancer cells expressing a mutant form of c-Myc that cannot be altered by PKCzeta (left) are more aggressive and more invasive than prostate cancer cells in which PKCzeta is able to keep tabs on c-Myc (right).
Credit: Sanford-Burnham Medical Research Institute

Researchers have identified how an enzyme called PKCζ (PKCzeta) suppresses prostate tumor formation. The finding, which also describes a molecular chain of events that controls cell growth and metastasis, could lead to novel ways to control disease progression.

Related Articles


Working in close collaboration, the labs of Maria T. Diaz-Meco, Ph.D., and Jorge Moscat, Ph.D., found that PKCζ controls the activation of a pro-tumor gene called c-Myc. Normally, PKCζ's alteration keeps c-Myc in check. But PKCζ levels are low in prostate and other cancers, leaving c-Myc free to enhance cell growth and metastasis. This study, appearing online April 2 in the Proceedings of the National Academy of Sciences, suggests that restoring PKCζ could provide a new approach to treating prostate cancer.

How PKCζ acts as a prostate tumor suppressor

Previous studies suggested that PKCζ might act as a tumor suppressor -- but that wasn't clear in the case of prostate cancer. In their study, the team learned of PKCζ's role after genetically engineering mice so they lacked the enzyme altogether.

"In this study, we assessed the role of PKCζ in prostate cancer, and for the first time we used a knockout mouse for PKCζ to demonstrate that it's actually a tumor suppressor," Diaz-Meco said. "But, I think the major advance in this paper is that we found out how PKCζ is a tumor suppressor in prostate cancer."

In their study, the researchers found that PKCζ suppresses tumors in cooperation with a gene called PTEN. PTEN has been long known to act as a tumor suppressor, and it's also well-established that its mutated form is common in prostate cancer.

But the loss of normal PTEN function alone doesn't lead to aggressive prostate cancer. According to this study, the loss of PKCζ and the resulting over-active c-Myc are also needed for aggressive prostate cancer to develop.

Potential approaches toward attacking prostate cancer may in the future involve activating PKCζ through gene therapy, or dealing with its inaction downstream -- perhaps by finding another way to inhibit c-Myc in the absence of PKCζ.

This research was funded by the U.S. National Institutes of Health (National Cancer Institute grants R01CA134530, R01CA132847, and 5P30CA030199-31; National Institute of Allergy and Infectious Diseases grant R01AI072581; National Institute of Diabetes and Digestive and Kidney Diseases grant R01DK088107) and the Department of Defense (grant DoD-PC080441).


Story Source:

The above story is based on materials provided by Sanford-Burnham Medical Research Institute. The original article was written by Bruce Lieberman. Note: Materials may be edited for content and length.


Journal Reference:

  1. Ji Young Kim, Tania Valencia, Shadi Abu-Baker, Juan Linares, Sang Jun Lee, Tomoko Yajima, Jing Chen, Alexey Eroshkin, Elias A. Castilla, Laurence M. Brill, Mario Medvedovic, Michael Leitges, Jorge Moscat, and Maria T. Diaz-Meco. c-Myc phosphorylation by PKCζ represses prostate tumorigenesis. Proceedings of the National Academy of Sciences, 2013; DOI: 10.1073/pnas.1221799110

Cite This Page:

Sanford-Burnham Medical Research Institute. "Newly identified tumor suppressor provides therapeutic target for prostate cancer." ScienceDaily. ScienceDaily, 1 April 2013. <www.sciencedaily.com/releases/2013/04/130401181504.htm>.
Sanford-Burnham Medical Research Institute. (2013, April 1). Newly identified tumor suppressor provides therapeutic target for prostate cancer. ScienceDaily. Retrieved March 6, 2015 from www.sciencedaily.com/releases/2013/04/130401181504.htm
Sanford-Burnham Medical Research Institute. "Newly identified tumor suppressor provides therapeutic target for prostate cancer." ScienceDaily. www.sciencedaily.com/releases/2013/04/130401181504.htm (accessed March 6, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, March 6, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com
Toddlers Drinking Coffee? Why You Shouldn't Share Your Joe

Toddlers Drinking Coffee? Why You Shouldn't Share Your Joe

Newsy (Mar. 5, 2015) A survey of Boston mothers and toddlers found that 15 percent of two-year-olds drink coffee and 2.5 percent of 1-year-olds. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins